Statistics from Altmetric.com
A 47-year-old man presented to the emergency department with fatigue and a rash. Two weeks prior to presentation, he had noticed a painful lesion in his left antecubital fossa (figure 1), which had gradually increased in size. Ten days later, he developed malaise, diffuse joint aches and a new rash (figure 2) over his torso, arms and legs. He had no palpitations, joint swelling or neurologic changes. Prior to the onset of his symptoms, he had vacationed in Wisconsin in early June—a Lyme-endemic region of the USA—and suspected that he may have had a tick bite to his left arm in the region adjacent to his initial rash. Physical exam was remarkable for a painful, indurated, erythematous plaque in the left antecubital fossa and multiple painless, erythematous patches with central clearing across his torso. He was afebrile, had no joint swelling or erythema and had no focal neurologic deficits. An ECG was normal, with no atrioventricular block, and a complete blood count and chemistry panel were unremarkable. The patient was clinically diagnosed with early disseminated Lyme disease and started on oral doxycycline for 3 weeks. Lyme serology studies drawn in the emergency department later returned with elevated IgM antibodies, supporting the diagnosis. On completion of treatment, the patient had complete resolution of his symptoms.
Lyme disease is the clinical manifestation of infection by Borrelia burgdorferi, a spirochete transmitted by the bite of the Ixodes scapularis or Ixodes pacificus tick.1 These arthropods are endemic to the Northeast, Midwest and Pacific Coast regions of the USA and the vast majority of Lyme disease cases correspond to individuals who live, or travel to, these regions.1 Following a bite from the Ixodes tick, patients with Lyme disease typically present with erythema migrans (EM) at the bite site, classically described as a ‘bull’s-eye’ pattern but more commonly manifest as circular, homogeneous erythema.1 2 In the following weeks, the spirochete undergoes haematogenous spread, and early disseminated Lyme disease presents with variable cutaneous findings of EM, such as erythematous rings with central clearing, erythematous plaques or purpura.1 3 Neurologic complications, including cranial nerve palsies, radiculopathies, meningitis and rarely encephalitis, can be seen in early disseminated Lyme disease. Myopericarditis is also possible, typically presenting with atrioventricular block.1 Late disseminated Lyme disease often causes the neurologic and cardiac manifestations of early disease, as well as a migratory monoarticular or pauciarticular arthritis of large joints.1 3
Diagnosis of Lyme disease can be made based on the cutaneous findings alone, or by serologic testing, though antibodies may not be detectable in patients with EM during the early phase of disease.1 Guidelines for treatment depend on the symptoms present and the stage of illness. Early and early disseminated Lyme disease, even with cardiac involvement and cranial nerve palsies, may be treated with 14 days of doxycycline. Patients with Lyme meningitis, encephalitis, radiculopathies, symptomatic carditis or arthritis refractory to initial oral therapy require a 14-day course of parenteral antibiotic therapy, typically ceftriaxone.3
Erythema migrans (EM) is the hallmark lesion of early Lyme disease, classically described as a bull’s-eye pattern though more commonly manifest as a homogeneous patch. Multiple forms of EM are possible in early disseminated Lyme disease.
Practitioners should have a high suspicion for neurologic and cardiac complications in early disseminated Lyme disease.
Oral doxycycline is the antibiotic of choice for outpatient management of early disseminated Lyme disease, while late disseminated Lyme disease requires parenteral antibiotics.
Contributors PDB was involved in the care of the patient described in the case, wrote the manuscript, contributed to the editorial process and provided the photographs submitted. JSI was also involved in the clinical care of the patient, contributed significantly to edits and alterations to the manuscript and provided editorial guidance. Both PDB and JSI have approved of the manuscript submitted.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent Obtained.
Provenance and peer review Not commissioned; externally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.